Morgan M Y
Department of Medicine, Royal Free Hospital, London, UK.
Alcohol Alcohol. 1996 Mar;31(2):117-34. doi: 10.1093/oxfordjournals.alcalc.a008123.
Alcoholic hepatitis is a precirrhotic lesion; it develops in only a minority of chronic alcohol abusers even after decades of abuse. The clinical spectrum of disease varies from asymptomatic hepatomegaly to florid hepatocellular failure with gastrointestinal bleeding and hepatic encephalopathy. Corresponding variation is observed both in morbidity and mortality. The majority of individuals with mild to moderate alcoholic hepatitis improve significantly following abstinence from alcohol and the provision of a diet sufficient to meet their nutritional requirements; their long-term outcome is determined largely by their ability to maintain abstinence from alcohol. Individuals with severe alcoholic hepatitis require intensive nutritional support and vigorous management of the complications of their liver injury; their outcome is generally poor. A small, carefully selected subgroup of these very sick patients may benefit, at least in the short-term, from treatment with corticosteroids; the place of orthotopic hepatic transplantation, in this patient group, is still the subject of debate. No other treatment modalities have been shown to confer benefit consistently. A number of new therapeutic approaches have been proposed and need to be explored.
酒精性肝炎是一种肝硬化前病变;即使经过数十年的酗酒,也只有少数慢性酗酒者会患上这种疾病。疾病的临床谱从无症状肝肿大到伴有胃肠道出血和肝性脑病的严重肝细胞衰竭不等。发病率和死亡率也存在相应的差异。大多数轻度至中度酒精性肝炎患者在戒酒并提供足以满足其营养需求的饮食后会有显著改善;他们的长期预后很大程度上取决于保持戒酒的能力。重度酒精性肝炎患者需要强化营养支持和积极处理肝损伤并发症;他们的预后通常较差。在这些病情严重的患者中,经过精心挑选的一小部分患者可能至少在短期内会从皮质类固醇治疗中获益;原位肝移植在该患者群体中的地位仍存在争议。没有其他治疗方式被证明能持续带来益处。已经提出了一些新的治疗方法,需要进行探索。